Alnylam Pharmaceuticals shares owned by Neuberger Berman Group
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Neuberger Berman Group
from 13F filings
Historical chart of Neuberger Berman Group investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Neuberger Berman Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $60M | 131k | 456.00 |
| 2025-06-30 | $32M | 99k | 326.09 |
| 2025-03-31 | $27M | 98k | 270.02 |
| 2024-12-31 | $26M | 110k | 235.31 |
| 2024-09-30 | $29M | 106k | 275.03 |
| 2024-06-30 | $23M | 95k | 243.00 |
| 2024-03-31 | $14M | 91k | 149.45 |
| 2023-12-31 | $14M | 72k | 191.41 |
| 2023-09-30 | $16M | 90k | 177.10 |
| 2023-06-30 | $17M | 90k | 189.94 |
| 2023-03-31 | $18M | 90k | 200.32 |
| 2022-12-31 | $14M | 61k | 237.65 |
| 2022-09-30 | $965k | 4.8k | 200.29 |
| 2022-06-30 | $685k | 4.7k | 145.90 |
| 2022-03-31 | $953k | 6.3k | 151.63 |
| 2021-12-31 | $553k | 3.7k | 149.42 |
| 2018-12-31 | $209k | 2.9k | 72.80 |
| 2018-09-30 | $251k | 2.9k | 87.43 |
| 2018-06-30 | $326k | 3.3k | 98.52 |
| 2018-03-31 | $318k | 2.7k | 119.28 |
| 2017-12-31 | $339k | 2.7k | 127.16 |
| 2017-09-30 | $313k | 2.7k | 117.40 |
| 2017-06-30 | $229k | 2.9k | 79.71 |
| 2016-09-30 | $205k | 3.0k | 67.63 |
| 2015-03-31 | $470k | 4.5k | 104.44 |
| 2014-12-31 | $436k | 4.5k | 96.89 |
| 2014-09-30 | $351k | 4.5k | 78.00 |
| 2013-09-30 | $1.5M | 23k | 64.02 |